Etripamil
CAS No. 1593673-23-4
Etripamil( MSP-2017 | (-)-MSP-2017 )
Catalog No. M23694 CAS No. 1593673-23-4
Etripamil displays atrioventricular nodal conduction and prolongs atrioventricular nodal refractory periods by inhibiting calcium ion influx through the calcium slow channels in the atrioventricular node cells. Etripamil is an antagonist of short-acting L-type calcium-channel.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 68 | In Stock |
|
| 5MG | 112 | In Stock |
|
| 10MG | 173 | In Stock |
|
| 25MG | 312 | In Stock |
|
| 50MG | 461 | In Stock |
|
| 100MG | 693 | In Stock |
|
| 200MG | 1088 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEtripamil
-
NoteResearch use only, not for human use.
-
Brief DescriptionEtripamil displays atrioventricular nodal conduction and prolongs atrioventricular nodal refractory periods by inhibiting calcium ion influx through the calcium slow channels in the atrioventricular node cells. Etripamil is an antagonist of short-acting L-type calcium-channel.
-
DescriptionEtripamil displays atrioventricular nodal conduction and prolongs atrioventricular nodal refractory periods by inhibiting calcium ion influx through the calcium slow channels in the atrioventricular node cells. Etripamil is an antagonist of short-acting L-type calcium-channel. It has a rapid onset of action designed for intranasal administration. It is also used to treat Paroxysmal Supraventricular Tachycardia.
-
In Vitro——
-
In Vivo——
-
SynonymsMSP-2017 | (-)-MSP-2017
-
PathwayGPCR/G Protein
-
TargetCalcium Channel
-
RecptorL-type calcium channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1593673-23-4
-
Formula Weight452.59
-
Molecular FormulaC27H36N2O4
-
Purity>98% (HPLC)
-
SolubilityEthanol : 110 mg/mL (243.05 mM; Need ultrasonic)
-
SMILESO=C(OC)C1=CC=CC(CCN(CCC[C@](C2=CC=C(OC)C(OC)=C2)(C#N)C(C)C)C)=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Stambler BS, et al. Etripamil Nasal Spray for Rapid Conversion of Supraventricular Tachycardia to Sinus Rhythm. J Am Coll Cardiol. 2018 Jul 31;72(5):489-497.
molnova catalog
related products
-
Nifedipine
Nifedipine(Adalat), a potent vasodilator agent with calcium antagonistic action.
-
Darodipine
Darodipine is a dihydropyridine type Ca+2 antagonist.
-
Mirogabalin besylate
Mirogabalin besylate (DS-5565) is a novel potent, selective ligand of the α2δ subunit of voltage-gated calcium channels with Kd of 13.5/22.7/27.0/47.6 nM for huamn α2δ-1, human α2δ-2, rat α2δ-1 and rat α2δ-2 subunits, respectively.
Cart
sales@molnova.com